MedTrace Logo

Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy

NCT06104371 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 459

Last updated 2026-02-23

No results posted yet for this study

Summary

Magnetic tracer injected before preoperative chemotherapy in breast cancer patients for sentinel lymph node detection. Also, magnetic tracer in combination with magnetic clip for index node identification.

Conditions

Interventions

DEVICE

Magtrace

Sentinel lymph node tracer and metastatic lymph node clip

Sponsors & Collaborators

  • Uppsala University

    collaborator OTHER

  • Region Västmanland

    collaborator OTHER

  • University Hospital, Linkoeping

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • The University of Hong Kong-Shenzhen Hospital

    collaborator OTHER

  • Royal Marsden NHS Foundation Trust

    collaborator OTHER

  • University of Athens

    collaborator OTHER

  • University College Dublin

    collaborator OTHER

  • Vastra Gotaland Region

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06104371 on ClinicalTrials.gov